WuXi Biologics
Offering End-to-End Solutions
WuXi XDC provides single-source discovery, development and manufacturing services for antibody drug conjugates (ADCs) and other novel bioconjugates. These comprehensive, integrated CRDMO services include the key intermediates, such as the chemical payload-linkers and the biologics (e.g., monoclonal, bispecific and multispecific antibodies or other recombinant proteins), in addition to the bioconjugate drug substance and drug product. This one-stop approach and the fact all services are within one-hour drive allows us to provide an unprecedented streamlined platform that cuts in half the time it takes to develop and manufacture these complex modalities. Use the interactive “service map” below to learn more.
Watch our video to learn more about the WuXi XDC integrated services advantage.
The WuXi XDC one-stop service and technology platform provides for our clients an unmatched value chain for the development of ADCs and other bioconjugates including conjugated diagnostic and imaging reagents.
All activities and services performed at WuXi XDC are conducted within 1-2 hours (driving), thus providing an unprecedented geographic advantage.
All activities and services performed at WuXi XDC are conducted within 1-2 hours (driving), thus providing an unprecedented geographic advantage.
Utilizing our high trained staff of scientists and engineers and supported by a leadership team, many of which possess 10-20 years industry experience, we provide world-class expertise across all facets of ADC/bioconjugate discovery, development, and GMP manufacturing. This expert guidance enables right-first-time project execution and timely troubleshooting and resolution if technical challenges arise.
Clients worldwide
Ongoing, integrated CMC development programs*
Ongoing late-stage, integrated (Phase II / III) programs*
Successful INDs filed by our clients, enabled through WuXi XDC services
*Integrated programs comprise product development and manufacturing programs contracted to us by our clients that utilize multiple WuXi XDC development capabilities / technologies or services (e.g., cell line development, process development, analytical development, formulation and drug product development etc.) and GMP manufacturing (drug substance, drug product or both)
As a leading Contract Research, Development and Manufacturing Organization(CRDMO), we greatly simplify ADC and other bioconjugate drug development and enable our clients and partners to quickly bring high quality biotherapeutics to the clinic and beyond for the benefit of parients worldwide.
We are dedicated to implementing sustainable and eco-friendly business practices by building a comprehensive and integrated Environmental, Health and Safety (EHS) management system, sourcing ethically, reducing our environmental footprint, advocating reduced energy consumption, minimizing effluent, and acting responsibly to reduce operational impact on the environment.
You are leaving WuXi Biologics Website, after which our Privacy Notice will not apply. Please keep it in mind the protection of your privacy. Are you willing to proceed?
